The Pulmonary Drug Delivery market is a subset of the larger Drug Delivery market, which focuses on the delivery of drugs to the lungs. This type of delivery is used to treat a variety of respiratory diseases, such as asthma, COPD, and cystic fibrosis. Pulmonary drug delivery systems are designed to deliver drugs directly to the lungs, allowing for a more targeted and efficient delivery of medication. These systems can be used to deliver both small and large molecules, and can be administered through inhalation, nebulization, or other methods. The Pulmonary Drug Delivery market is highly competitive, with a number of companies offering products and services. Some of the major players in the market include GlaxoSmithKline, Boehringer Ingelheim, Novartis, Merck, and AstraZeneca. Show Less Read more
ASK A QUESTION
We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.
